(13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzothiasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(8,8-diphenyl-5-pyridin-2-yl-4H-[1,4]benzoxasilino[2,3-g]carbazol-4-id-3-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzoxasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(5,13,13-triphenyl-8-pyridin-2-yl-9H-[1,4]benzazasilino[3,2-g]carbazol-9-id-10-yl)silane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(8,8,13-triphenyl-5-pyridin-2-yl-4H-[1,4]benzazasilino[2,3-g]carbazol-4-id-3-yl)silane;pentakis(palladium(2+))
C322H210N22O2Pd5SSi10 — CID 157399959
Data last refreshed: (MolForge compound catalog, from PubChem)
About (13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzothiasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(8,8-diphenyl-5-pyridin-2-yl-4H-[1,4]benzoxasilino[2,3-g]carbazol-4-id-3-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzoxasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(5,13,13-triphenyl-8-pyridin-2-yl-9H-[1,4]benzazasilino[3,2-g]carbazol-9-id-10-yl)silane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(8,8,13-triphenyl-5-pyridin-2-yl-4H-[1,4]benzazasilino[2,3-g]carbazol-4-id-3-yl)silane;pentakis(palladium(2+))
(13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzothiasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(8,8-diphenyl-5-pyridin-2-yl-4H-[1,4]benzoxasilino[2,3-g]carbazol-4-id-3-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzoxasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(5,13,13-triphenyl-8-pyridin-2-yl-9H-[1,4]benzazasilino[3,2-g]carbazol-9-id-10-yl)silane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(8,8,13-triphenyl-5-pyridin-2-yl-4H-[1,4]benzazasilino[2,3-g]carbazol-4-id-3-yl)silane;pentakis(palladium(2+)) (PubChem CID 157399959) has the molecular formula C322H210N22O2Pd5SSi10 and a molecular weight of 5264.40 g/mol. Its IUPAC name is (13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzothiasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(8,8-diphenyl-5-pyridin-2-yl-4H-[1,4]benzoxasilino[2,3-g]carbazol-4-id-3-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzoxasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(5,13,13-triphenyl-8-pyridin-2-yl-9H-[1,4]benzazasilino[3,2-g]carbazol-9-id-10-yl)silane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(8,8,13-triphenyl-5-pyridin-2-yl-4H-[1,4]benzazasilino[2,3-g]carbazol-4-id-3-yl)silane;pentakis(palladium(2+)).
Molecular Properties
| Compound Name | (13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzothiasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(8,8-diphenyl-5-pyridin-2-yl-4H-[1,4]benzoxasilino[2,3-g]carbazol-4-id-3-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzoxasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(5,13,13-triphenyl-8-pyridin-2-yl-9H-[1,4]benzazasilino[3,2-g]carbazol-9-id-10-yl)silane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(8,8,13-triphenyl-5-pyridin-2-yl-4H-[1,4]benzazasilino[2,3-g]carbazol-4-id-3-yl)silane;pentakis(palladium(2+)) |
|---|---|
| PubChem CID | 157399959 |
| Molecular Formula | C322H210N22O2Pd5SSi10 |
| Molecular Weight | 5264.40 g/mol |
| Exact Mass | 5256.96 |
| IUPAC Name | (13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzothiasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(8,8-diphenyl-5-pyridin-2-yl-4H-[1,4]benzoxasilino[2,3-g]carbazol-4-id-3-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;(13,13-diphenyl-8-pyridin-2-yl-9H-[1,4]benzoxasilino[3,2-g]carbazol-9-id-10-yl)-(12H-imidazo[1,2-f]phenanthridin-12-id-11-yl)-diphenylsilane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(5,13,13-triphenyl-8-pyridin-2-yl-9H-[1,4]benzazasilino[3,2-g]carbazol-9-id-10-yl)silane;12H-imidazo[1,2-f]phenanthridin-12-id-11-yl-diphenyl-(8,8,13-triphenyl-5-pyridin-2-yl-4H-[1,4]benzazasilino[2,3-g]carbazol-4-id-3-yl)silane;pentakis(palladium(2+)) |
| SMILES | [Pd+2].[Pd+2].[Pd+2].[Pd+2].[Pd+2].[c-]1c([Si](c2[c-]c3c(cc2)c2c4c(ccc2n3-c2ccccn2)N(c2ccccc2)c2ccccc2[Si]4(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)ccc2c1c1nccn1c1ccccc21.[c-]1c([Si](c2[c-]c3c(cc2)c2c4c(ccc2n3-c2ccccn2)Oc2ccccc2[Si]4(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)ccc2c1c1nccn1c1ccccc21.[c-]1c([Si](c2[c-]c3c(cc2)c2c4c(ccc2n3-c2ccccn2)Sc2ccccc2[Si]4(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)ccc2c1c1nccn1c1ccccc21.[c-]1c([Si](c2[c-]c3c(cc2)c2c4c(ccc2n3-c2ccccn2)[Si](c2ccccc2)(c2ccccc2)c2ccccc2N4c2ccccc2)(c2ccccc2)c2ccccc2)ccc2c1c1nccn1c1ccccc21.[c-]1c([Si](c2[c-]c3c(cc2)c2c4c(ccc2n3-c2ccccn2)[Si](c2ccccc2)(c2ccccc2)c2ccccc2O4)(c2ccccc2)c2ccccc2)ccc2c1c1nccn1c1ccccc21 |
| InChI | InChI=1S/2C68H45N5Si2.2C62H40N4OSi2.C62H40N4SSi2.5Pd/c1-6-22-48(23-7-1)72-60-34-18-19-35-63(60)75(51-28-12-4-13-29-51,52-30-14-5-15-31-52)64-42-41-61-66(67(64)72)57-40-38-54(47-62(57)73(61)65-36-20-21-43-69-65)74(49-24-8-2-9-25-49,50-26-10-3-11-27-50)53-37-39-55-56-32-16-17-33-59(56)71-45-44-70-68(71)58(55)46-53;1-6-22-48(23-7-1)72-60-34-18-19-35-64(60)75(51-28-12-4-13-29-51,52-30-14-5-15-31-52)67-62(72)42-41-61-66(67)57-40-38-54(47-63(57)73(61)65-36-20-21-43-69-65)74(49-24-8-2-9-25-49,50-26-10-3-11-27-50)53-37-39-55-56-32-16-17-33-59(56)71-45-44-70-68(71)58(55)46-53;1-5-19-43(20-6-1)68(44-21-7-2-8-22-44,47-32-34-49-50-27-13-14-28-53(50)65-40-39-64-62(65)52(49)41-47)48-33-35-51-55(42-48)66(59-31-17-18-38-63-59)54-36-37-57-61(60(51)54)69(45-23-9-3-10-24-45,46-25-11-4-12-26-46)58-30-16-15-29-56(58)67-57;1-5-19-43(20-6-1)68(44-21-7-2-8-22-44,47-32-34-49-50-27-13-14-28-53(50)65-40-39-64-62(65)52(49)41-47)48-33-35-51-55(42-48)66(59-31-17-18-38-63-59)54-36-37-58-61(60(51)54)67-56-29-15-16-30-57(56)69(58,45-23-9-3-10-24-45)46-25-11-4-12-26-46;1-5-19-43(20-6-1)68(44-21-7-2-8-22-44,47-32-34-49-50-27-13-14-28-53(50)65-40-39-64-62(65)52(49)41-47)48-33-35-51-55(42-48)66(59-31-17-18-38-63-59)54-36-37-57-61(60(51)54)69(45-23-9-3-10-24-45,46-25-11-4-12-26-46)58-30-16-15-29-56(58)67-57;;;;;/h2*1-45H;3*1-40H;;;;;/q5*-2;5*+2 |
| InChIKey | CSELZYFQDVJHME-UHFFFAOYSA-N |
| XLogP | 46.67 |
| TPSA | 200.54 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 362 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 5264.40 |
| LogP ≤ 5 | 46.67 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 25 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157399959 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.